SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 18, 2004
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of registrant as specified in charter)
|
Delaware |
|
001-16789 |
|
04-3565120 |
|
(State
or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS
Employer |
|
|
|
|
|
|
|
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 |
||||
|
(Address of Principal Executive Offices) (Zip Code) |
||||
|
|
|
|
|
|
|
(781) 647-3900 |
||||
|
(Registrant’s telephone number, including area code) |
||||
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
|
(c) |
Exhibits. |
|
|
|
|
|
|
|
|
|
Exhibit |
|
Description |
|
|
|
|
|
|
|
99.1 |
|
Press Release dated February 18, 2004, titled “Inverness Medical Innovations Announces Fourth Quarter 2003 Results” |
Item 12. Results of Operations and Financial Condition.
On February 18, 2004, Inverness Medical Innovations, Inc. issued a press release titled “Inverness Medical Innovations Announces Fourth Quarter 2003 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
INVERNESS MEDICAL INNOVATIONS, INC. |
||
|
|
|
||
|
|
|
||
|
Date: February 18, 2004 |
By: |
/s/ Christopher Lindop |
|
|
|
|
Christopher Lindop |
|
|
|
|
Chief Financial Officer |
|
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated February 18, 2004, titled “Inverness Medical Innovations Announces Fourth Quarter 2003 Results” |
4